Najla Guthrie to take helm at Wellbeing Digital Sciences

KGK Science president Najla Guthrie will take over the CEO role at Vancouver-based Wellbeing Digital Sciences at month’s end; will remain in London and retain KGK position

WELLBEING DIGITAL SCIENCES Inc., a Vancouver-based evidence-based healthcare company focused on clinical solutions, artificial intelligence-powered digital therapeutics and contract research, has announced that Najla Guthrie, the current chief research officer and president of London-based KGK Science Inc., has been appointed as CEO of Wellbeing effective March 31, 2022.

KGK Science is a wholly owned subsidiary of Wellbeing Digital Sciences, which was formerly known as KetamineOne Capital Limited.  

Story Continues Below

 

Under Guthrie’s leadership, KGK, founded in 1997, has become a leading North American contract research organization that primarily provides high-quality clinical research trials with a focus on the nutraceutical cannabis, and emerging psychedelic industries. KGK’s other existing service lines include regulatory support and compliance solutions, participant recruitment, research support services and consulting services. Guthrie has published over 50 articles in peer-reviewed journals and has given numerous presentations at both the national and international levels.

Guthrie will replace interim CEO Adam Deffett, who will continue in his former capacity as vice president of capital markets at Wellbeing. Guthrie will retain her position at KGK and remain in London.

Story Continues Below

 

“I greatly appreciate the opportunity to lead Wellbeing as we continue to pursue our vision of becoming a leader in mental health and wellness across North America,” says Guthrie in a released statement. “We have a leadership team with great depth, decades of experience and detailed knowledge of the industry. Naturally, I will continue to steward KGK Science forward as a leading clinical research organization.”